Impact of Frailty on Post-Treatment Dysphagia in Patients with Head and Neck Cancer
- PMID: 39196352
- PMCID: PMC12145293
- DOI: 10.1007/s00455-024-10754-7
Impact of Frailty on Post-Treatment Dysphagia in Patients with Head and Neck Cancer
Abstract
In the rising and frail head and neck cancer (HNC) population, geriatric assessments are crucial. Frail HNC patients often experience dysphagia. The coexistence of dysphagia and frailty presents complex health challenges, however, there is limited evidence on the prognostic value of frailty on post-treatment dysphagia. This study explores the relationship between pre-treatment frailty status and post-treatment dysphagia in HNC patients. A retrospective data analysis from the OncoLifeS data-biobank at the University Medical Center Groningen of 242 patients diagnosed with HNC between 2014 and 2016. The study involved several physical, functional and psychological pre-treatment geriatric assessments, and frailty screening using the Groningen Frailty Indicator (GFI) and the Geriatric-8 screening tool (G8). Outcome measures were swallowing-related quality of life (HNSW-QoL) and toxicity-related dysphagia evaluations (CTCAE-D) at 3, 6, 12 and 24 months. Linear mixed-effects models assessed factors associated with HNSW-QoL and CTCAE-D. Frail patients consistently reported worse HNSW-QoL and CTCAE-D than non-frail patients over time, with symptoms increasing at 3 months, but gradually decreasing by 24 months. Frailty status (G8 or GFI) was a significant predictor for lower HNSW-QoL (β = 11.770 and 10.936, both p < 0.001), and lower CTCAE-D (β = 0.245, p = 0.058; β = 0.331, p = 0.019), respectively. In this study, frailty was found to be associated with a worse of swallowing-related quality of life, and with increased toxicity-related dysphagia. These findings provide insights for the identification of HNC patients at higher risk of post-treatment swallowing-related issues, and offer opportunities for optimizing their post-treatment swallowing outcomes.
Keywords: Dysphagia; Frailty; Geriatric assessment; Head and neck cancer; Toxicity.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the OncoLifeS scientific committee, oncological data-biobank approved by the medical ethical committee of the UMCG and is registered in the Dutch Trial Register (registration number NL7839). All patients provided written informed consent for the participation in OncoLifeS. Conflict of interest: Javier Hurtado-Oliva declared receiving grant support from the Department of Human Capital Development, Chilean National Scholarship Program for Graduate Studies, of the National Agency of Research and Development (ANID), Government of Chili. Scholarship ID 72210512. Hans Paul van der Laan, Julius de Vries, Roel J.H.M. Steenbakkers, Gyorgy B. Halmos, and Inge Wegner, declare that they have no conflict of interest.
Figures


References
-
- Kinsella K, Phillips DR. Global aging: the challenge of success. Popul Bull. 2005;60(1).
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424. - PubMed
-
- Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, et al. Update on Head and Neck Cancer: current knowledge on epidemiology, risk factors, molecular features and Novel therapies. Oncology. 2015;89(3):125–36. - PubMed
-
- van Deudekom FJ, Schimberg AS, Kallenberg MH, Slingerland M, van der Velden LA, Mooijaart SP. Functional and cognitive impairment, social environment, frailty and adverse health outcomes in older patients with head and neck cancer, a systematic review. Oral Oncol. 2017;64:27–36. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical